This is not the most recent version of the article. View current version (24 JAN 2007)

Intervention Review

Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease

  1. RW Orrell*,
  2. JM Lane,
  3. MA Ross

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 19 APR 2004

DOI: 10.1002/14651858.CD002829.pub2


How to Cite

Orrell RW, Lane JM, Ross MA. Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002829. DOI: 10.1002/14651858.CD002829.pub2.

Author Information

  1. Royal Free and University College Medical School, Department of Clinical Neurosciences, London, UK

*RW Orrell, Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London (Royal Free Campus), Rowland Hill Street, London, NW3 2QG, UK. r.orrell@rfc.ucl.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 19 APR 2004

SEARCH

This is not the most recent version of the article. View current version (24 JAN 2007)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.